Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq in human neuroblastoma SK-N-BE(2)-C cells treated with DMSO, TSA or E6R

ABSTRACT: RNA-seq in human neuroblastoma SK-N-BE(2)-C cells treated with DMSO, TSA or E6R

PROVIDER: PRJNA872096 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq in human neuroblastoma SK-N-BE(2)-C cells treated with DMSO, TSA or E6R

Project description:As part of a larger study identifying novel HDAC complex inhibitors, cells were treated with 0.8% DMSO, 1 μM TSA, or 25 μM E6R to investigate changes in gene expression levels.

2025-08-22 | GSE211773 | GEO

RNA-seq in MaV208 WT and mutant Saccharomyces cerevisiae yeast strains treated with DMSO, TSA, or E6R

Project description:As part of a larger study identifying novel HDAC complex inhibitors, WT cells were treated with DMSO, 20 μM TSA or 50 μM E6R to investigate changes in gene expression levels. Also, cultures of rpd3Δ and sin3Δ mutant strains treated with DMSO were investigated.

2025-08-22 | GSE211775 | GEO

mTORC inhibition of neuroblastoma SK-N-BE(2)c cells cultured under hypoxic conditions

Project description:Differential expression of the oxygen sensitive hypoxia-inducible transcription factor (HIF) subunits HIF-1a and HIF-2a occurs in many tumor types, but the underlying regulatory mechanisms remain poorly understood. Here we investigate the role of mTOR complex in the regulation of HIF expression in cells cultured under hypoxic conditions. Neuroblastoma SK-N-BE(2)c cells were treated with DMSO or the mTORC complex inhibitor PP242 and cultured at hypoxia for 24, 48 or 72 hours.

2016-07-03 | E-GEOD-69833 | biostudies-arrayexpress

A549 treated with CISPLATIN/TSA VS CONTROL

Project description:WE TEST THE PROTEIN CHANGES WHEN A549 cells treated with DDP OR TSA.

2024-06-23 | PXD052305 | Pride

Gene expression analysis of RNAs isolated from TSA-untreated and TSA-treated human keratinocytes

Project description:In order to identify the TSA responsive genes, we performed a gene expression microarray analysis for the RNAs isolated from TSA-untreated and TSA-treated human keratinocytes

2018-12-31 | GSE121902 | GEO

Gene expression profiling in neuroblastoma cell lines treated with THZ531 or DMSO

Project description:Gene expression profiling in neuroblastoma cell lines treated with THZ531 or DMSO

| PRJNA450793 | ENA

Genome-wide analysis of parental and wild-type SK-N-Be(2)C neuroblastoma cell lines as well as those co-treated with the histone deacetylase inhibitor SAHA

Project description:Analysis of varied biologic pathways in neuroblastoma SK-N-Be(2)C cells grown in doxorubicin and/or SAHA. We hypothesized that SK-N-Be(2)C cells undergo a mesenchymal change through mesenchymal change resulting in a more invasive as well as drug resistant phenotype, and that the mechanism of SAHAs effect on drug resistance may be revealed through this analysis. Total RNA was isolated from wild type, SAHA treated wild type cells, doxorubicin resistant, and SAHA treated doxorubicin resistant SK-N-Be(2)C cell lines in triplicate.

2016-05-31 | E-GEOD-47669 | biostudies-arrayexpress

Genome-wide analysis of parental wild-type and derived doxorubicin resistant SK-N-SH neuroblastoma cell lines as well as those co-treated with the histone deacetylase inhibitor SAHA

Project description:Analysis of varied biologic pathways in neuroblastoma SK-N-SH cells grown in doxorubicin and/or SAHA. The hypothesis was that SK-N-SH cells undergo a mesenchymal change through mesenchymal change resulting in a more invasive as well as drug resistant phenotype, and that the mechanism of SAHAs effect on drug resistance may be revealed through this analysis. Total RNA was isolated from wild type, SAHA treated wild type cells, doxorubicin resistant, and SAHA treated doxorubicin resistant SK-N-SH cell lines in triplicate.

2016-05-31 | E-GEOD-47668 | biostudies-arrayexpress

RNA-seq of CLB-GA neuroblastoma cell line treated with Celastrol against DMSO treated controls

Project description:RNA-seq of CLB-GA neuroblastoma cell line treated with Celastrol against DMSO treated controls

| PRJEB39240 | ENA

Developmental programs in childhood neuroblastoma [scRNA-seq SK-N-AS]

Project description:Neuroblastoma is a pediatric tumor of the developing sympathetic nervous system. We investigate the developmental origin of neuroblastoma, the role of oncogenic MYCN in blocking normal differentiation and evaluate therapeutic interventions to overcome differentiation blocks. Here, we provide single cell expression profiles (scRNA-seq MARS-seq) of SK-N-AS cells (n=603).

2020-12-18 | GSE163430 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data